Concepedia

Petros Fessas

PF

Statistics

Publications

12

Citations

691

H-Index

11

Active since

2016

Affiliations

Imperial College London(Current)

Hammersmith Hospital

Humanitas University

New York Hospital Queens

Cornell University

Petros Fessas is an author at Imperial College London specializing in oncology, medicine, and cancer immunotherapy.

Publications per year

2016–2023

12

Publications

12

Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy.

David J. Pinato, Sam M. Murray, Alejandro Forner et al. · Journal for ImmunoTherapy of Cancer · 2021 · 202 citations · Full text

Life Sciences, Immunology, Oncology +17

Risk stratification of Barrett's oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study

Caryn S. Ross-Innes, Hamza Chettouh, Achilleas Achilleos et al. · The Lancet. Gastroenterology & hepatology · 2016 · 125 citations · Full text

Medicine, Clinical Sciences, Epidemiology +16

Immune Checkpoint Inhibitors for Child-Pugh Class B Advanced Hepatocellular Carcinoma

Enrui Xie, Yee Hui Yeo, Bernhard Scheiner et al. · JAMA Oncology · 2023 · 82 citations · Full text

Life Sciences, Immunology, Oncology +14

Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma

Petros Fessas, Muntaha Naeem, Matthias Pinter et al. · Liver Cancer · 2021 · 62 citations · Full text

Medicine, Immunology, Oncology +12

Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study

Petros Fessas, Ahmed O. Kaseb, Yinghong Wang et al. · Journal for ImmunoTherapy of Cancer · 2020 · 61 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

1–5 of 12